LAU159

CAS No. 2055050-87-6

LAU159( LAU 159 )

Catalog No. M13189 CAS No. 2055050-87-6

LAU159 is a potent, functionally selective positive modulator of α6β3γ2 GABAA receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 163 In Stock
5MG 231 In Stock
10MG 417 In Stock
25MG 690 In Stock
50MG 918 In Stock
100MG 1283 In Stock
200MG Get Quote In Stock
500MG 2576 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LAU159
  • Note
    Research use only, not for human use.
  • Brief Description
    LAU159 is a potent, functionally selective positive modulator of α6β3γ2 GABAA receptor.
  • Description
    LAU159 is a potent, functionally selective positive modulator of α6β3γ2 GABAA receptor.Other Indication Phase 3 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    LAU 159
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    GAT
  • Recptor
    GAT
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    2055050-87-6
  • Formula Weight
    325.752
  • Molecular Formula
    C17H12ClN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC1=CC=CC(=C1)N2C(=O)C3=CN=C4C=CC(=CC4=C3N2)Cl
  • Chemical Name
    8-chloro-2-(3-methoxyphenyl)-2H,3H,5H-pyrazolo[4,3-c]quinolin-3-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Treven M, et al. Br J Pharmacol. 2018 Feb;175(3):419-428.
molnova catalog
related products
  • 4-Amino-3-hydroxybut...

    Agent for improving learning or memory [US6803366]Gamma Hydroxybutyric Acid, commonly abbreviated GHB, is a therapeutic drug which is illegal in multiple countries.

  • SAGE-217

    SAGE-217 (Zuranolone, SAGE217) is a potent, orally active GABAA receptor positive allosteric modulator with EC50 of 296 and 163 nM for α1β2γ2 and α4β3δ GABAA r eceptors, respectively.

  • CI-966 hydrochloride

    CI-966 is a potent, selective inhibitor of the GABA transporter GAT-1 with IC50 of 0.26 and 1.2 uM for human and rat GAT-1, respectively.